EP-104GI

Eupraxia Pharmaceuticals Inc. · Phase 1 active Small molecule

At a glance

Generic name	EP-104GI
Sponsor	Eupraxia Pharmaceuticals Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EP-104GI CI brief — competitive landscape report
EP-104GI updates RSS · CI watch RSS
Eupraxia Pharmaceuticals Inc. portfolio CI